Patent directory · USPTO A61K / A61P
Patents matching “China Medical University”
75 pharma patents match "China Medical University" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 75 pharmaceutical patents matching "China Medical University" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12397034
Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons
granted -
US 12357666
Traditional Chinese herbal plant composition for improving symptoms of liver cancer patients and compatibility method thereof
granted -
US 12319729
Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12251428
Hydrogel composition, hydrogel biomedical material, method for facilitating regeneration of bone and manufacturing method of hydrogel composition
granted -
US 12228572
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
granted -
US 12226437
Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell
granted -
US 12221483
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12012454
Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 11891628
Method for biomimetic culture of urothelial cells and uses thereof
granted -
US 11760980
Induced pluripotent stem cells (IPSCS) and applications thereof
granted -
US 11723946
Methods for regulating transcription of multiple genes and expression of multiple targets
granted -
US 11685784
Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 11591330
HIF-2a small-molecule inhibitor and use thereof
granted -
US 11554140
Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
granted -
US 11529373
Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage
granted -
US 11479611
HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
granted -
US 11458171
Engineering stem cells for cancer therapy
granted -
US 11357759
Composition including ADAM9 inhibitor and the use thereof
granted -
US 11117888
Irreversible inhibitors of pyruvate kinase M2 and the use thereof
granted -
US 11110129
Method for treating multiple sclerosis
granted -
US 11066378
Caffeic acid derivatives for anti-angiogenesis
granted -
US 11040055
Method of treating diabetic retinopathy or wet type adult macular degeneration
granted -
US 10988733
Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue
granted -
US 10787413
Derivatives of curcuminoids and use thereof as an anticancer agent
granted